Prudential Financial
EDIT icon

Prudential Financial’s Editas Medicine EDIT Stock Holding History

Prudential Financial’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$60.7K Sell
18,740
-47,620
-72% -$139K ﹤0.01% 2395
2026
Q1 		$164K Buy
+66,360
New +$140K ﹤0.01% 2171
2025
Q4 		– Sell
-11,457
Closed -$39.8K – 2279
2025
Q3 		$39.8K Sell
11,457
-1,480
-11% -$4.13K ﹤0.01% 2361
2025
Q2 		$28.5K Sell
12,937
-67,000
-84% -$110K ﹤0.01% 2379
2025
Q1 		$92.7K Sell
79,937
-117,040
-59% -$172K ﹤0.01% 2137
2024
Q4 		$250K Buy
196,977
+51,600
+35% +$131K ﹤0.01% 2038
2024
Q3 		$496K Buy
145,377
+42,369
+41% +$184K ﹤0.01% 2222
2024
Q2 		$481K Buy
103,008
+42,507
+70% +$240K ﹤0.01% 2201
2024
Q1 		$449K Buy
+60,501
New +$503K ﹤0.01% 2211
2022
Q1 		– Sell
-5,805
Closed -$219K – 2628
2021
Q4 		$219K Sell
5,805
-4,828
-45% -$166K ﹤0.01% 2513
2021
Q3 		$441K Buy
10,633
+5,141
+94% +$282K ﹤0.01% 2178
2021
Q2 		$311K Buy
5,492
+128
+2% +$4.73K ﹤0.01% 2295
2021
Q1 		$226K Buy
5,364
+369
+7% +$21K ﹤0.01% 2369
2020
Q4 		$350K Buy
+4,995
New +$205K ﹤0.01% 2199

Other funds holding EDIT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

Prudential Financial's EDIT Position: Q2 2026 in Review

Prudential Financial reduced its Editas Medicine (EDIT) stake by 72% in Q2 2026, selling an estimated $139K and leaving 18,740 shares worth $60.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2395.

Prudential Financial first reported a position in EDIT in Q4 2020 and has held it in 14 quarters since. The position peaked at $496K in Q3 2024. 149 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • Prudential Financial held 18,740 shares of Editas Medicine worth $60.7K as of Q2 2026.
  • Prudential Financial sold 47,620 Editas Medicine shares in Q2 2026, an estimated $139K.
  • Editas Medicine made up ﹤0.01% of Prudential Financial's portfolio in Q2 2026, its #2395 holding.
  • Prudential Financial first reported a position in Editas Medicine in Q4 2020 and has held it in 14 quarters since.
  • Prudential Financial's Editas Medicine position peaked at $496K in Q3 2024.
  • 149 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.